HHS/ASPR Awards $19.3M Contract for COVID-19 Injector Sets to Apiject Systems
Contract Overview
Contract Amount: $19,344,396 ($19.3M)
Contractor: Apiject Systems America, Inc.
Awarding Agency: Department of Health and Human Services
Start Date: 2020-05-08
End Date: 2027-07-02
Contract Duration: 2,611 days
Daily Burn Rate: $7.4K/day
Competition Type: NOT COMPETED
Number of Offers Received: 1
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: COVID-19 INJECTOR SETS CONTRACT TRANSITIONING FROM THE DOD/AF TO HHS/ASPR. DOD/AF CONTRACT NO.FA872620C0022.
Place of Performance
Location: STAMFORD, FAIRFIELD County, CONNECTICUT, 06905
Plain-Language Summary
Department of Health and Human Services obligated $19.3 million to APIJECT SYSTEMS AMERICA, INC. for work described as: COVID-19 INJECTOR SETS CONTRACT TRANSITIONING FROM THE DOD/AF TO HHS/ASPR. DOD/AF CONTRACT NO.FA872620C0022. Key points: 1. Contract awarded to Apiject Systems America, Inc. for COVID-19 injector sets. 2. Transitioning from DOD/AF to HHS/ASPR, indicating a shift in federal pandemic response. 3. The contract is a definitive, firm-fixed-price award. 4. No small business participation noted in this award.
Value Assessment
Rating: fair
The contract value of $19.3 million for injector sets appears reasonable given the context of pandemic preparedness. However, without specific unit cost data or comparison to similar pandemic-related medical supply contracts, a precise valuation is difficult.
Cost Per Unit: N/A
Competition Analysis
Competition Level: sole-source
This contract was not competed, suggesting a sole-source or limited competition award. This approach may expedite delivery during critical needs but can limit price discovery and potentially lead to higher costs compared to a fully competed process.
Taxpayer Impact: The lack of competition may result in taxpayers paying a premium for these essential supplies, though the urgency of pandemic response is a mitigating factor.
Public Impact
Ensures availability of critical medical supplies for public health emergencies. Supports the national strategy for pandemic preparedness and response. Potential for rapid deployment of necessary equipment during health crises.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Lack of competition
- No small business participation
Positive Signals
- Supports critical pandemic response
- Long-term contract duration
Sector Analysis
This contract falls under miscellaneous manufacturing, specifically related to medical devices. Spending in this sector is often driven by public health needs and national security requirements, with significant government investment during health crises.
Small Business Impact
The data indicates that this contract was not awarded to a small business. There is no indication of set-asides for small businesses in this particular award, which could limit opportunities for smaller companies in this supply chain.
Oversight & Accountability
The transition from DOD/AF to HHS/ASPR suggests a coordinated federal effort. Oversight will be crucial to ensure timely delivery, quality control, and appropriate utilization of funds, especially given the non-competitive nature of the award.
Related Government Programs
- All Other Miscellaneous Manufacturing
- Department of Health and Human Services Contracting
- Office of Assistant Secretary for Preparedness and Response Programs
Risk Flags
- Sole-source award limits price competition.
- Lack of transparency on unit costs.
- No small business participation.
- Potential for overpayment due to non-competitive nature.
- Long contract duration may not adapt to evolving needs.
Tags
all-other-miscellaneous-manufacturing, department-of-health-and-human-services, ct, definitive-contract, 10m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Health and Human Services awarded $19.3 million to APIJECT SYSTEMS AMERICA, INC.. COVID-19 INJECTOR SETS CONTRACT TRANSITIONING FROM THE DOD/AF TO HHS/ASPR. DOD/AF CONTRACT NO.FA872620C0022.
Who is the contractor on this award?
The obligated recipient is APIJECT SYSTEMS AMERICA, INC..
Which agency awarded this contract?
Awarding agency: Department of Health and Human Services (Office of Assistant Secretary for Preparedness and Response).
What is the total obligated amount?
The obligated amount is $19.3 million.
What is the period of performance?
Start: 2020-05-08. End: 2027-07-02.
What is the projected unit cost for these COVID-19 injector sets, and how does it compare to industry benchmarks or previous government purchases?
The provided data does not include specific unit cost information or a breakdown of the total award value by units. To assess value, a comparison with similar injector sets procured by other federal agencies or private sector entities would be necessary. Without this, it's challenging to determine if the $19.3 million represents a fair price per unit.
What are the specific justifications for awarding this contract on a sole-source basis, and what measures are in place to mitigate potential risks associated with non-competitive procurement?
The justification for a sole-source award typically relates to urgency, unique capabilities, or lack of viable alternatives. HHS/ASPR should have documented these reasons. Mitigation strategies might include rigorous negotiation of terms, performance monitoring, and contingency planning for future procurements to ensure better competition.
How will the effectiveness of these injector sets be measured, and what is the plan for their distribution and utilization within the broader public health response framework?
Effectiveness is likely tied to their performance in administering vaccines or treatments during public health emergencies. Distribution and utilization plans would be managed by HHS/ASPR, coordinating with state and local health departments. Monitoring usage and feedback will be key to assessing their real-world impact.
Industry Classification
NAICS: Manufacturing › Other Miscellaneous Manufacturing › All Other Miscellaneous Manufacturing
Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
Competition & Pricing
Extent Competed: NOT COMPETED
Solicitation Procedures: ONLY ONE SOURCE
Offers Received: 1
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Address: 2 HIGH RIDGE PARK FL 1, STAMFORD, CT, 06905
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $19,344,396
Exercised Options: $19,344,396
Current Obligation: $19,344,396
Actual Outlays: $15,622,421
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES
Cost or Pricing Data: NO
Timeline
Start Date: 2020-05-08
Current End Date: 2027-07-02
Potential End Date: 2027-07-02 00:00:00
Last Modified: 2026-01-05
More Contracts from Apiject Systems America, Inc.
- Covid-19 Dhhs, Apiject Injector Sets — $152.2M (Department of Defense)
Other Department of Health and Human Services Contracts
- Contact Center Operations (CCO) — $5.5B (Maximus Federal Services, Inc.)
- TAS::75 0849::TAS Oper of Govt R&D Goco Facilities — $4.8B (Leidos Biomedical Research Inc)
- THE Purpose of This Contract IS to Provide the Full Complement of Services Necessary to Care for UC in ORR Custody Including Facilities Set-Up, Maintenance, and Support Internal and Perimeter (IF Applicable) Security, Direct Care and Supervision Inc — $3.5B (Rapid Deployment Inc)
- Contact Center Operations — $2.6B (Maximus Federal Services, Inc.)
- Federal Contract — $2.4B (Leidos Biomedical Research Inc)
View all Department of Health and Human Services contracts →